Hepatocellular carcinoma (HCC) represents the fifth most common malignancy and the third cancer-related cause of death worldwide. The aim of this review was to clarify the role of local treatments for HCC, analyzing the indications and defining future perspectives.
The Evolving Role of Local Treatments for HCC in the Third Millennium / Magistri, Paolo; Tarantino, Giuseppe; Ballarin, Roberto; Berretta, Massimiliano; Pecchi, Annarita; Ramacciato, Giovanni; DI Benedetto, Fabrizio. - In: ANTICANCER RESEARCH. - ISSN 0250-7005. - 37:2(2017), pp. 389-401. [10.21873/anticanres.11331]
The Evolving Role of Local Treatments for HCC in the Third Millennium
MAGISTRI, PAOLO;Tarantino, Giuseppe;Pecchi, Annarita;DI Benedetto, Fabrizio
2017
Abstract
Hepatocellular carcinoma (HCC) represents the fifth most common malignancy and the third cancer-related cause of death worldwide. The aim of this review was to clarify the role of local treatments for HCC, analyzing the indications and defining future perspectives.
| File | Dimensione | Formato | |
|---|---|---|---|
|
389.full.pdf
Open access
Tipologia:
Versione pubblicata dall'editore
Dimensione
219.7 kB
Formato
Adobe PDF
|
219.7 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
